Variant report

Variant	esv1794268
Chromosome Location	chr15:59614874-59637355
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:274)
CpG islands
(count:183)
Chromatin interactive
region (count:4)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:274 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr15:59631420-59631787	HepG2	liver:	n/a	n/a
2	ARID3A	chr15:59621813-59622340	HepG2	liver:	n/a	n/a
3	ATF2	chr15:59627326-59627901	GM12878	blood:	n/a	n/a
4	BATF	chr15:59625642-59625911	GM12878	blood:	n/a	n/a
5	BATF	chr15:59625595-59625885	GM12878	blood:	n/a	n/a
6	BATF	chr15:59627461-59627806	GM12878	blood:	n/a	n/a
7	BCL3	chr15:59627402-59627796	GM12878	blood:	n/a	n/a
8	BCLAF1	chr15:59627357-59628140	GM12878	blood:	n/a	n/a
9	BHLHE40	chr15:59621890-59622064	GM12878	blood:	n/a	n/a
10	CEBPB	chr15:59622953-59623151	HepG2	liver:	n/a	chr15:59623023-59623034
11	CEBPB	chr15:59626425-59626491	Hela-S3	cervix:	n/a	chr15:59626433-59626444
12	CEBPB	chr15:59626291-59626559	A549	lung:	n/a	chr15:59626433-59626444
13	CEBPB	chr15:59626356-59626472	HepG2	liver:	n/a	chr15:59626433-59626444
14	CEBPB	chr15:59626176-59626711	A549	lung:	n/a	chr15:59626433-59626444
15	CEBPB	chr15:59626222-59626496	HepG2	liver:	n/a	chr15:59626433-59626444
16	CEBPB	chr15:59627274-59628024	GM12878	blood:	n/a	n/a
17	CEBPB	chr15:59622895-59623150	HepG2	liver:	n/a	chr15:59623023-59623034
18	CEBPB	chr15:59621713-59622372	A549	lung:	n/a	chr15:59622058-59622070
19	CEBPB	chr15:59620808-59621009	Hela-S3	cervix:	n/a	chr15:59620911-59620922 chr15:59620910-59620923 chr15:59620910-59620921
20	CEBPB	chr15:59622961-59623169	A549	lung:	n/a	chr15:59623023-59623034
21	CEBPB	chr15:59620782-59621060	IMR90	lung:	n/a	chr15:59620911-59620922 chr15:59620910-59620923 chr15:59620910-59620921
22	CEBPB	chr15:59620760-59621079	HepG2	liver:	n/a	chr15:59620911-59620922 chr15:59620910-59620923 chr15:59620910-59620921
23	CEBPB	chr15:59626372-59626466	IMR90	lung:	n/a	chr15:59626433-59626444
24	CEBPB	chr15:59621706-59622322	HCT-116	colon:	n/a	chr15:59622058-59622070
25	CEBPB	chr15:59620784-59621040	A549	lung:	n/a	chr15:59620911-59620922 chr15:59620910-59620923 chr15:59620910-59620921
26	CEBPB	chr15:59631480-59631820	HepG2	liver:	n/a	chr15:59631651-59631662
27	CEBPB	chr15:59625471-59625850	HepG2	liver:	n/a	chr15:59625777-59625788
28	CEBPB	chr15:59626289-59626566	HepG2	liver:	n/a	chr15:59626433-59626444
29	CTCF	chr15:59623080-59623230	GM12871	blood:	n/a	n/a
30	CTCF	chr15:59623000-59623150	HepG2	liver:	n/a	n/a
31	CTCF	chr15:59622400-59622550	AG10803	skin:	n/a	n/a
32	CTCF	chr15:59633960-59634110	K562	blood:	n/a	n/a
33	CTCF	chr15:59626640-59626790	Hela-S3	cervix:	n/a	n/a
34	CTCF	chr15:59616780-59616930	HRE	kidney:	n/a	n/a
35	CTCF	chr15:59616820-59616970	GM12865	blood:	n/a	n/a
36	CTCF	chr15:59616800-59616950	GM12869	blood:	n/a	n/a
37	CTCF	chr15:59623065-59623093	H1-hESC	embryonic stem cell:	n/a	n/a
38	CTCF	chr15:59616720-59616870	Hela-S3	cervix:	n/a	n/a
39	CTCF	chr15:59616740-59616890	HCFaa	heart:	n/a	n/a
40	CTCF	chr15:59623000-59623150	A549	lung:	n/a	n/a
41	CTCF	chr15:59616800-59616950	GM12871	blood:	n/a	n/a
42	CTCF	chr15:59634251-59634300	GM10248	blood:	n/a	n/a
43	CTCF	chr15:59616820-59616970	GM12871	blood:	n/a	n/a
44	CTCF	chr15:59616840-59616990	GM12874	blood:	n/a	n/a
45	CTCF	chr15:59616820-59616970	GM12867	blood:	n/a	n/a
46	CUX1	chr15:59621890-59622197	GM12878	blood:	n/a	n/a
47	E2F4	chr15:59630288-59630488	MCF10A-Er-Src	breast:	n/a	n/a
48	EBF1	chr15:59621717-59622136	GM12878	blood:	n/a	n/a
49	EBF1	chr15:59620037-59620508	GM12878	blood:	n/a	n/a
50	EBF1	chr15:59620182-59620485	GM12878	blood:	n/a	n/a

(count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr15:59623309-59623359	HL-60	blood:	n/a
2	chr15:59626352-59626402	SK-N-SH_RA	brain:	n/a
3	chr15:59626352-59626402	T-47D	breast:	n/a
4	chr15:59621569-59621619	IMR90	lung:	fetal
5	chr15:59623309-59623359	CMK	blood:	n/a
6	chr15:59623309-59623359	NHDF-neo	bronchial:	n/a
7	chr15:59621569-59621619	SK-N-MC	brain:	n/a
8	chr15:59621569-59621619	PFSK-1	brain:	n/a
9	chr15:59623309-59623359	SK-N-MC	brain:	n/a
10	chr15:59626352-59626402	HUVEC	blood vessel:	n/a
11	chr15:59621569-59621619	A549	lung:	n/a
12	chr15:59621569-59621619	CMK	blood:	n/a
13	chr15:59623309-59623359	Hela-S3	cervix:	n/a
14	chr15:59626352-59626402	SK-N-SH	brain:	n/a
15	chr15:59623309-59623359	HCM	heart:	n/a
16	chr15:59623309-59623359	LNCaP	prostate:	n/a
17	chr15:59626352-59626402	RPTEC	kidney:	n/a
18	chr15:59626352-59626402	K562	blood:	n/a
19	chr15:59626352-59626402	NB4	blood:	n/a
20	chr15:59623309-59623359	SAEC	small airway:	n/a
21	chr15:59621569-59621619	HCM	heart:	n/a
22	chr15:59621569-59621619	NH-A	brain:	n/a
23	chr15:59626352-59626402	HPAEpiC	pulmonary alveolar:	n/a
24	chr15:59623309-59623359	BJ	skin:	n/a
25	chr15:59621569-59621619	HL-60	blood:	n/a
26	chr15:59623309-59623359	H1-hESC	embryonic stem cell:	embryo
27	chr15:59623309-59623359	HAEpiC	amniotic membrane:	n/a
28	chr15:59623309-59623359	ECC-1	luminal epithelium:	n/a
29	chr15:59621569-59621619	NT2-D1	testis:	n/a
30	chr15:59621569-59621619	GM19239	blood:	n/a
31	chr15:59626352-59626402	GM12878	blood:	n/a
32	chr15:59621569-59621619	T-47D	breast:	n/a
33	chr15:59623309-59623359	GM12892	blood:	n/a
34	chr15:59626352-59626402	BJ	skin:	n/a
35	chr15:59623309-59623359	RPTEC	kidney:	n/a
36	chr15:59621569-59621619	HPAEpiC	pulmonary alveolar:	n/a
37	chr15:59626352-59626402	AG04449	skin:	fetal
38	chr15:59623309-59623359	BE2_C	brain:	n/a
39	chr15:59626352-59626402	HRE	kidney:	n/a
40	chr15:59626352-59626402	GM19239	blood:	n/a
41	chr15:59626352-59626402	NHBE	bronchial:	n/a
42	chr15:59623309-59623359	NB4	blood:	n/a
43	chr15:59621569-59621619	MCF-7	breast:	n/a
44	chr15:59621569-59621619	GM12892	blood:	n/a
45	chr15:59621569-59621619	LNCaP	prostate:	n/a
46	chr15:59626352-59626402	GM06990	blood:	n/a
47	chr15:59626352-59626402	HRPEpiC	eye:	n/a
48	chr15:59621569-59621619	HepG2	liver:	n/a
49	chr15:59623309-59623359	HNPCEpiC	eye:	n/a
50	chr15:59623309-59623359	SK-N-SH_RA	brain:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr15:59624048..59626995-chr15:59627954..59630263,2	K562	blood:
2	chr15:59625699..59628162-chr15:59663501..59666309,3	MCF-7	breast:
3	chr15:59637008..59639426-chr15:59640704..59642854,2	MCF-7	breast:
4	chr15:59624048..59626995-chr15:59627954..59630263,2	K562	blood:

No data

Variant related genes	Relation type
RNU6-212P	TF binding region
RNU6-212P	CpG island
ENSG00000157483	chromatin interactions
ENSG00000157470	chromatin interactions

Extended variants
information (count: 935 )
Associated
traits (count: 61 )

Variant overlapped rSNPs/rCNVs (count:935 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs35170708	chr15:59614913-59614914	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs187168183	chr15:59614934-59614935	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs531178044	chr15:59614943-59614944	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs201837682	chr15:59614945-59614946	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs539599794	chr15:59614947-59614948	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs552065567	chr15:59614963-59614964	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs570287245	chr15:59614990-59614991	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs537327478	chr15:59614996-59614997	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs549381012	chr15:59615043-59615044	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs373597395	chr15:59615083-59615084	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs574083698	chr15:59615084-59615085	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs192024122	chr15:59615089-59615090	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs375778527	chr15:59615132-59615133	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs147339938	chr15:59615177-59615178	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs545647386	chr15:59615187-59615188	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs564291865	chr15:59615188-59615189	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs4775150	chr15:59615203-59615204	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs201568038	chr15:59615205-59615206	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs71425859	chr15:59615219-59615220	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs576436904	chr15:59615234-59615235	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs185391048	chr15:59615250-59615251	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs562105692	chr15:59615291-59615292	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs558548125	chr15:59615317-59615318	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs112464219	chr15:59615322-59615323	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs559552772	chr15:59615333-59615334	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs10569332	chr15:59615368-59615369	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs398043376	chr15:59615389-59615390	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs114624975	chr15:59615405-59615406	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs72746885	chr15:59615526-59615527	Weak transcription Strong transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs370440468	chr15:59615529-59615530	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs190074313	chr15:59615567-59615568	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs531147415	chr15:59615569-59615570	Weak transcription Strong transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs78913098	chr15:59615602-59615603	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs76420004	chr15:59615619-59615620	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs538349405	chr15:59615641-59615642	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs150584357	chr15:59615648-59615649	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs139643971	chr15:59615678-59615679	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs535053095	chr15:59615679-59615680	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs553849804	chr15:59615686-59615687	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs374110608	chr15:59615688-59615689	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs368056612	chr15:59615696-59615697	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs371857861	chr15:59615709-59615710	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs149289618	chr15:59615718-59615719	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs7168263	chr15:59615723-59615724	Weak transcription Enhancers Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs543749170	chr15:59615728-59615729	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs58967797	chr15:59615735-59615736	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs146246840	chr15:59615748-59615749	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs182246319	chr15:59615803-59615804	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs541099578	chr15:59615814-59615815	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs185581243	chr15:59615817-59615818	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:61)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Schizophrenia	19415332	CNVD
Breast cancer	22522925	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Testicular germ cell tumor	18059402	CNVD
cataract	16735990	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Medulloblastoma	21979893	CNVD
spastic paraplegia with thinning of corpus callosum	19105190	CNVD
Schizophrenia	21324950	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Disease	21824424	CNVD
Melanoma	18172304	CNVD
Gastric cancer	17167181	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Colorectal cancer	16272173	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Multiple myeloma	17550852	CNVD
Intellectual disability	22102821	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Prostate cancer	16573809	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Multiple myeloma	20724749	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Prostate cancer	18632612	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Cancer	21129771	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Abnormal phenotypes	18644119	CNVD
Cancer	16751803	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital diaphragmatic hernia	21341218	CNVD
Holoprosencephaly	21359414	CNVD
Myelofibrosis	22110671	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Mental retardation	17124404	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:617 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:59600000-59627400	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
2	chr15:59606600-59621200	Weak transcription	Fetal Kidney	kidney
3	chr15:59606800-59615600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr15:59606800-59621400	Weak transcription	Gastric	stomach
5	chr15:59606800-59623000	Weak transcription	Lung	lung
6	chr15:59606800-59631600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
7	chr15:59607000-59620200	Weak transcription	Esophagus	oesophagus
8	chr15:59608600-59615000	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
9	chr15:59608600-59619000	Weak transcription	Sigmoid Colon	Sigmoid Colon
10	chr15:59608600-59619400	Weak transcription	Rectal Mucosa Donor 29	rectum
11	chr15:59608600-59621400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
12	chr15:59608600-59621400	Weak transcription	Ovary	ovary
13	chr15:59608600-59622600	Weak transcription	Brain Inferior Temporal Lobe	brain
14	chr15:59608600-59623200	Weak transcription	Psoas Muscle	Psoas
15	chr15:59608600-59623400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
16	chr15:59608600-59625800	Weak transcription	HMEC	breast
17	chr15:59608800-59621400	Weak transcription	Duodenum Mucosa	Duodenum
18	chr15:59609600-59619000	Weak transcription	Rectal Mucosa Donor 31	rectum
19	chr15:59609800-59620200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
20	chr15:59609800-59620400	Weak transcription	HSMM	muscle
21	chr15:59609800-59620800	Weak transcription	NH-A	brain
22	chr15:59609800-59621400	Weak transcription	Pancreas	Pancrea
23	chr15:59610000-59619000	Weak transcription	Stomach Mucosa	stomach
24	chr15:59610200-59617600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
25	chr15:59610200-59620400	Weak transcription	Osteobl	bone
26	chr15:59610200-59623000	Weak transcription	Left Ventricle	heart
27	chr15:59610200-59627200	Weak transcription	Cortex derived primary cultured neurospheres	brain
28	chr15:59610400-59617400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
29	chr15:59610600-59616200	Weak transcription	NHDF-Ad	bronchial
30	chr15:59610600-59620400	Weak transcription	Fetal Heart	heart
31	chr15:59610600-59623000	Weak transcription	Aorta	Aorta
32	chr15:59611200-59617600	Weak transcription	Hela-S3	cervix
33	chr15:59611200-59617800	Weak transcription	NHEK	skin
34	chr15:59612200-59625800	Weak transcription	HUVEC	blood vessel
35	chr15:59613800-59626000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
36	chr15:59614000-59615000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
37	chr15:59614000-59615200	Enhancers	Fetal Intestine Small	intestine
38	chr15:59614000-59616400	Enhancers	GM12878-XiMat	blood
39	chr15:59614000-59620400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
40	chr15:59614200-59621600	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
41	chr15:59614400-59615000	Weak transcription	Fetal Intestine Large	intestine
42	chr15:59614400-59615200	Enhancers	Liver	Liver
43	chr15:59614600-59615000	Enhancers	HepG2	liver
44	chr15:59614600-59615200	Enhancers	A549	lung
45	chr15:59615000-59615200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
46	chr15:59615000-59619800	Weak transcription	HepG2	liver
47	chr15:59615200-59615600	Weak transcription	A549	lung
48	chr15:59615200-59616000	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
49	chr15:59615200-59619200	Weak transcription	Liver	Liver
50	chr15:59615200-59620000	Weak transcription	Fetal Intestine Small	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links